Gestational choriocarcinoma: an unusual presentation with response to gemcitabine and surgery
Authors:
Open Access
- 4 March 2004
- journal article
- case report
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 111 (4) , 382-384
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Low-Risk Persistent Gestational Trophoblastic Disease: Outcome After Initial Treatment With Low-Dose Methotrexate and Folinic Acid From 1992 to 2000Journal of Clinical Oncology, 2002
- Choriocarcinoma and partial hydatidiform molesThe Lancet, 2000
- Etoposide and Cisplatin/Etoposide, Methotrexate, and Actinomycin D (EMA) Chemotherapy for Patients With High-Risk Gestational Trophoblastic Tumors Refractory to EMA/Cyclophosphamide and Vincristine Chemotherapy and Patients Presenting With Metastatic Placental Site Trophoblastic TumorsJournal of Clinical Oncology, 2000
- Phase II Trial of Gemcitabine in Refractory Germ Cell TumorsJournal of Clinical Oncology, 1999
- Gemcitabine in Patients With Relapsed or Cisplatin-Refractory Testicular CancerJournal of Clinical Oncology, 1999
- EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.Journal of Clinical Oncology, 1997
- Treatment of Resistant Gestational Choriocarcinoma with Taxol: A Report of Two CasesGynecologic Oncology, 1996